Browse by People

Davison, AS ORCID: 0000-0001-5501-4475, Norman, B ORCID: 0000-0001-9293-4852, Milan, AM ORCID: 0000-0002-0452-2338, Hughes, AT, Khedr, M ORCID: 0000-0002-4998-2397, Rovensky, J, Gallagher, JA ORCID: 0000-0002-0852-279X and Ranganath, LR (2018) Assessment of the Effect of Once Daily Nitisinone Therapy on 24-h Urinary Metadrenalines and 5-Hydroxyindole Acetic Acid Excretion in Patients with Alkaptonuria After 4 Weeks of Treatment. JIMD REPORTS: FOCUS ISSUE: ADULTS AND METABOLISM, VOL 41, 41. pp. 1-10.

Khedr, M ORCID: 0000-0002-4998-2397, Judd, S, Briggs, MC, Hughes, AT, Milan, AM ORCID: 0000-0002-0452-2338, Stewart, RMK, Lock, EA, Gallagher, JA ORCID: 0000-0002-0852-279X and Ranganath, LR (2018) Asymptomatic Corneal Keratopathy Secondary to Hypertyrosinaemia Following Low Dose Nitisinone and a Literature Review of Tyrosine Keratopathy in Alkaptonuria. JIMD REPORTS, VOL 40, 40. pp. 31-37.

Collapse authors list.
Ranganath, LR, Milan, AM, Hughes, AT, Davison, AS ORCID: 0000-0001-5501-4475, Khedr, M, Norman, BP ORCID: 0000-0001-9293-4852, Bou-Gharios, G, Gallagher, JA ORCID: 0000-0002-0852-279X, Gornall, M, Jackson, R et al (show 4 more authors) , Imrich, R, Rovensky, J, Rudebeck, M and Olsson, B (2022) Characterization of changes in the tyrosine pathway by 24-h profiling during nitisinone treatment in alkaptonuria. Molecular Genetics and Metabolism Reports, 30. p. 100846.

Collapse authors list.
Davison, AS ORCID: 0000-0001-5501-4475, Harrold, JA ORCID: 0000-0002-0899-4586, Hughes, G, Norman, B ORCID: 0000-0001-9293-4852, Devine, J, Usher, J, Hughes, AT, Khedr, M ORCID: 0000-0002-4998-2397, Gallagher, JA ORCID: 0000-0002-0852-279X, Milan, AM ORCID: 0000-0002-0452-2338 et al (show 2 more authors) , Halford, JC ORCID: 0000-0003-1629-3189 and Ranganath, LR (2018) Clinical and biochemical assessment of depressive symptoms in patients with Alkaptonuria before and after two years of treatment with nitisinone. Molecular Genetics and Metabolism, 125 (1-2). pp. 135-143.

Collapse authors list.
Griffin, R ORCID: 0000-0003-4521-948X, Psarelli, EE ORCID: 0000-0002-3102-0288, Cox, TF, Khedr, M ORCID: 0000-0002-4998-2397, Milan, AM ORCID: 0000-0002-0452-2338, Davison, AS ORCID: 0000-0001-5501-4475, Hughes, AT, Usher, JL, Taylor, S, Loftus, N et al (show 17 more authors) , Daroszewska, A ORCID: 0000-0002-6692-6610, West, E, Jones, A, Briggs, M, Fisher, M, McCormick, M, Judd, S, Vinjamuri, S, Sireau, N, Dillon, JP ORCID: 0000-0002-7055-5664, Devine, JM, Hughes, G, Harrold, J ORCID: 0000-0002-0899-4586, Barton, GJ, Jarvis, JC, Gallagher, JA ORCID: 0000-0002-0852-279X and Ranganath, LR (2018) Data on items of AKUSSI in Alkaptonuria collected over three years from the United Kingdom National Alkaptonuria Centre and the impact of nitisinone. Data in Brief, 20. pp. 1620-1628.

Collapse authors list.
Ranganath, LR, Milan, AM, Hughes, AT, Davison, AS, Khedr, M, Norman, BP, Bou-Gharios, G, Gallagher, JA, Imrich, R, Arnoux, JB et al (show 2 more authors) , Rudebeck, M and Olsson, B (2022) Determinants of tyrosinaemia during nitisinone therapy in alkaptonuria. SCIENTIFIC REPORTS, 12 (1). 16083-.

Collapse authors list.
Norman, BP ORCID: 0000-0001-9293-4852, Sutherland, H, Wilson, PJM, Rutland, DA, Milan, AM, Hughes, AT, Davison, AS, Khedr, M, Jarvis, JC, Gallagher, JA et al (show 2 more authors) , Bou-Gharios, G and Ranganath, LR (2024) Hepatobiliary circulation and dominant urinary excretion of homogentisic acid in a mouse model of alkaptonuria. Journal of inherited metabolic disease.

Collapse authors list.
Ranganath, LR, Khedr, M ORCID: 0000-0002-4998-2397, Milan, AM ORCID: 0000-0002-0452-2338, Davison, AS ORCID: 0000-0001-5501-4475, Hughes, AT, Usher, JL, Taylor, S, Loftus, N, Daroszewska, A ORCID: 0000-0002-6692-6610, West, E et al (show 17 more authors) , Jones, A, Briggs, M, Fisher, M, McCormick, M, Judd, S, Vinjamuri, S, Griffin, R ORCID: 0000-0003-4521-948X, Psarelli, EE ORCID: 0000-0002-3102-0288, Cox, TF, Sireau, N, Dillon, JP ORCID: 0000-0002-7055-5664, Devine, JM, Hughes, G, Harrold, J ORCID: 0000-0002-0899-4586, Barton, GJ, Jarvis, JC and Gallagher, JA ORCID: 0000-0002-0852-279X (2018) Nitisinone arrests ochronosis and decreases rate of progression of Alkaptonuria: Evaluation of the effect of nitisinone in the United Kingdom National Alkaptonuria Centre. Molecular genetics and metabolism, 125 (1-2). pp. 127-134.

Milan, AM ORCID: 0000-0002-0452-2338, Hughes, AT, Davison, AS ORCID: 0000-0001-5501-4475, Khedr, M ORCID: 0000-0002-4998-2397, Rovensky, J, Psarelli, EE ORCID: 0000-0002-3102-0288, Cox, TF, Rhodes, NP ORCID: 0000-0002-5173-7032, Gallagher, JA and Ranganath, LR (2019) Quantification of the flux of tyrosine pathway metabolites during nitisinone treatment of Alkaptonuria. SCIENTIFIC REPORTS, 9 (1). 10024-.

Davison, AS ORCID: 0000-0001-5501-4475, Norman, BP ORCID: 0000-0001-9293-4852, Smith, EA, Devine, J, Usher, J, Hughes, AT, Khedr, M ORCID: 0000-0002-4998-2397, Milan, AM ORCID: 0000-0002-0452-2338, Gallagher, JA ORCID: 0000-0002-0852-279X and Ranganath, LR (2018) Serum Amino Acid Profiling in Patients with Alkaptonuria Before and After Treatment with Nitisinone. JIMD REPORTS: FOCUS ISSUE: ADULTS AND METABOLISM, VOL 41, 41. pp. 109-117.

Collapse authors list.
Cox, T, Psarelli, EE ORCID: 0000-0002-3102-0288, Taylor, S, Shepherd, HR, Robinson, M, Barton, G, Mistry, A, Genovese, F, Braconi, D, Giustarini, D et al (show 12 more authors) , Rossi, R, Santucci, A, Khedr, M ORCID: 0000-0002-4998-2397, Hughes, A, Milan, A ORCID: 0000-0002-0452-2338, Taylor, LF, West, E, Sireau, N, Dillon, JP ORCID: 0000-0002-7055-5664, Rhodes, N ORCID: 0000-0002-5173-7032, Gallagher, JA and Ranganath, L (2019) Subclinical ochronosis features in alkaptonuria: A cross-sectional study. BMJ Innovations, 5 (2-3). pp. 82-91.

Collapse authors list.
Ranganath, LR, Hughes, AT, Davison, AS, Khedr, M, Olsson, B, Rudebeck, M, Imrich, R, Norman, BP ORCID: 0000-0001-9293-4852, Bou-Gharios, G, Gallagher, JA ORCID: 0000-0002-0852-279X et al (show 1 more authors) and Milan, AM (2022) Temporal adaptations in the phenylalanine/tyrosine pathway and related factors during nitisinone-induced tyrosinaemia in alkaptonuria. Molecular genetics and metabolism. S1096-7192(22)00325-0-.

Ranganath, LR, Khedr, M, Mistry, A, Vinjamuri, S and Gallagher, JA ORCID: 0000-0002-0852-279X (2021) Treatment of osteoporotic fractures in alkaptonuria by teriparatide stimulates bone formation and decreases fracture rate - A report of two cases. BONE REPORTS, 15. 101151-.